These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 5029675)

  • 1. [Effectiveness of rifampicin and ethambutol in chronic pulmonary tuberculosis].
    Anastasatu K; Sibila S; Kaufman S; Bercha O; Vais F
    Probl Tuberk; 1972; 50(5):28-30. PubMed ID: 5029675
    [No Abstract]   [Full Text] [Related]  

  • 2. [Treatment of chronic destructive pulmonary tuberculosis with rifampicin and ethambutol].
    Shmelev NA; Korotaev GA; Kaminskaia AA
    Probl Tuberk; 1971; 49(7):21-4. PubMed ID: 5146090
    [No Abstract]   [Full Text] [Related]  

  • 3. [Rifampicin and ethambutol in the treatment of chronic, destructive forms of pulmonary tuberculosis].
    Chmelev NA; Korotajev GA; Kaminskaja AA
    G Ital Chemioter; 1972; 19(2):1-6. PubMed ID: 4579712
    [No Abstract]   [Full Text] [Related]  

  • 4. [Long-term results of treatment with rifampicin and ethambutol in hyperchronic pulmonary tuberculosis with polyresistant bacilli].
    Anastasatu C; Sibila S
    Ftiziologia; 1973; 22(5):477-84. PubMed ID: 4751363
    [No Abstract]   [Full Text] [Related]  

  • 5. [Early results of treatment of chronic pulmonary tuberculosis with rifampicin and ethambutol adminstered intermittently once or twice a week preceded by a 3-month continuous administration].
    Kost A; Moskwa Z
    Gruzlica; 1975 Aug; 43(8):719-26. PubMed ID: 1158177
    [No Abstract]   [Full Text] [Related]  

  • 6. [Rifampicin and ethambutol in treating chronic destructive pulmonary tuberculosis].
    Roslik SM; Iakovleva LM; Zhitnaia VI; Grushevskiĭ ES; Poluianova RP
    Probl Tuberk; 1980 Jun; (6):30-3. PubMed ID: 7393907
    [No Abstract]   [Full Text] [Related]  

  • 7. [Rifampicin and ethambutol in the treatment of chronic destructive tuberculosis].
    Shmelev NA; Korotaev GA; Kaminskaia AA
    Probl Tuberk; 1971; 49(7):21-4. PubMed ID: 5162993
    [No Abstract]   [Full Text] [Related]  

  • 8. Combined treatment with rifampicin-ethambutol-capreomycin in chronic open pulmonary tuberculosis.
    Virchow C; Flemming J
    Acta Tuberc Pneumol Belg; 1969; 60(3):466-70. PubMed ID: 5371671
    [No Abstract]   [Full Text] [Related]  

  • 9. [Results of the use of rifampicin and ethambutol in complex treatment of chronic destructive pulmonary tuberculosis].
    Alimov ShA; Stoianovskiĭ EA
    Probl Tuberk; 1976; 3():27-31. PubMed ID: 967851
    [No Abstract]   [Full Text] [Related]  

  • 10. [On the effectiveness of rifampicin and ethambutol used in 3 different therapeutical schemes in drug-resistant chronic pulmonary tuberculosis].
    Andrian A; Ciobanu V; Cojocaru G; Borşaru I; Ciobanu D; Spirescu G; Roşianu D; Pescariu M
    Ftiziologia; 1971; 20(6):623-8. PubMed ID: 5162289
    [No Abstract]   [Full Text] [Related]  

  • 11. [Results of treatment of chronic tuberculosis with rifampicin and ethambutol at the sanatoria run by the Railroad Health Services].
    Ropek M; Bielecki T; Mysakowska H; Sosnowski K; Raczyński R; Pizlo S; Majchrzak A
    Gruzlica; 1974 May; 42(5):393-5. PubMed ID: 4464225
    [No Abstract]   [Full Text] [Related]  

  • 12. [Rifampicin, ethambutol and drugs of the 2d series in chemotherapy of chronic cavernous tuberculosis of the lungs].
    Mamolat AS; Bialik IB
    Probl Tuberk; 1979 Nov; (11):20-6. PubMed ID: 530963
    [No Abstract]   [Full Text] [Related]  

  • 13. [Intermittent treatment of "intractable chronic tuberculosis" by combined rifampicin-ethambutol: preliminary results of a controlled survey made in Algeria].
    Larbaoui D; Chaulet P; Grosset J; Abderrahim K; Oussedik N; Coucke C; Benabdallah L
    Rev Tuberc Pneumol (Paris); 1970 Jun; 34(4):559-66. PubMed ID: 4928583
    [No Abstract]   [Full Text] [Related]  

  • 14. [Daily and intermittent regimens using ethambutol and rifampicin in the treatment of unresponsive cases. (Evaluation after 1 year.) I. Clinical course].
    Horsfall PA
    Bull Int Union Tuberc; 1974; 49(1):447-51. PubMed ID: 4619566
    [No Abstract]   [Full Text] [Related]  

  • 15. [Characteristics of metabolic disorders in chronic destructive pulmonary tuberculosis after treatment with rifampicin and ethambutol].
    Kharakter ZhZ; Pavlenko AV
    Probl Tuberk; 1976 Nov; (11):44-9. PubMed ID: 1019127
    [No Abstract]   [Full Text] [Related]  

  • 16. [Pecularities of the healing process under the effect of rifampicin and ethambutol (experimental study)].
    Uvarova OA; Kozulicyna TI; Korotajev GA
    G Ital Chemioter; 1972; 19(2):11-5. PubMed ID: 4666005
    [No Abstract]   [Full Text] [Related]  

  • 17. [Treatment of chronic tuberculosis patients with ethambutol and protoionamide combined with rifampicin and capreomicin].
    Grassi C; Cornia G; Cirianni C; Garimoldi M; Ginesu F; Mandler F; Perna G; Pradella F
    G Ital Chemioter; 1968; 15(4):92-4. PubMed ID: 5744843
    [No Abstract]   [Full Text] [Related]  

  • 18. [Effectiveness of treatment of patients with destructive forms of pulmonary tuberculosis with rifampicin and ethambutol].
    Mavrotskiĭ VV
    Klin Med (Mosk); 1974 Dec; 52(12):31-4. PubMed ID: 4444241
    [No Abstract]   [Full Text] [Related]  

  • 19. [Maximum therapeutic efficiency of a guternary antitubercular preparation. (Streptomycin-ethambutol-rifampicin-isoniazid)].
    Almansa de Cara S
    Rev Clin Esp; 1972 May; 125(4):353-6. PubMed ID: 5080180
    [No Abstract]   [Full Text] [Related]  

  • 20. [Effect of rifampicin and ethambutol on indices of the sympathoadrenal system in patients with recurrent pulmonary tuberculosis].
    Grozovskaia MS
    Probl Tuberk; 1985; (10):38-40. PubMed ID: 4070203
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.